CAF-derived BHB modulates FXR1-Kbhb and NK-cell lipid metabolism in osteosarcoma
Yihan Yu, Wei Wu, Anzhen Ju, Lei Zhao, Guohui Liang, Yun Liu, Zengwu Shao, Feifei Pu, Binlong Zhong, Fengxia Chen, Jianxiang Liu, Zhicai Zhang · 2026
Read CAF-derived BHB modulates FXR1-Kbhb and NK-cell lipid metabolism in osteosarcoma by Yihan Yu, Wei Wu, Anzhen Ju, Lei Zhao, Guohui Liang, Yun Liu, Zengwu Shao, Feifei Pu, Binlong Zhong, Fengxia Chen, Jianxiang Liu, Zhicai Zhang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13618007.txt.
Description
Yihan Yu and eleven colleagues trace how support cells around a bone tumor weaken the immune attack on it. Osteosarcoma is the most common bone cancer in children and teens, and returns or spreads often end badly. Natural killer cells should kill tumor cells, but near the tumor they lose their strength.
Using shared cell cultures, the team found that cancer-associated fibroblasts blunt killer cell action. The killer cells shifted their energy use, burned more sugar, and lost power in their mitochondria. A fat-derived molecule, beta-hydroxybutyrate, released by the fibroblasts proved to be a key culprit. It altered a protein mark on FXR1 and cut the killer cells' fat burning. The work names a metabolic route worth targeting.
Catalog record
| CREATOR | Yihan Yu, Wei Wu, Anzhen Ju, Lei Zhao, Guohui Liang, Yun Liu, Zengwu Shao, Feifei Pu, Binlong Zhong, Fengxia Chen, Jianxiang Liu, Zhicai Zhang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 76 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |